"I think first and foremost, the most exciting part is the ability to build a women's health-focused company and to be the only one doing it, to be the most focused company on women's health, which is an area that it is about time," Organon managing director Nirelle Tolstoshev told BioPharmaDispatch. …
The 'new' Organon springs to life after MSD spinout
June 3, 2021 Latest NewsBioPharmaBioPharmaDispatch Executive
Latest Video
New Stories
-
If the minister is too embarrassed to respond, it might be the best of bad responses
September 19, 2025 - - Latest News -
Mark Butler acknowledges his concerns over potential impact of US pharmaceutical pricing reforms
September 19, 2025 - - Latest News -
CSL appoints new global head of search to accelerate innovation through strategic partnerships
September 18, 2025 - - Latest News -
Pharmacy Guild of Australia acquires Member Benefits Australia
September 18, 2025 - - Latest News -
Sanofi promotes a national dialogue on health literacy and trust
September 18, 2025 - - Latest News -
Island Pharmaceuticals reports breakthrough survival data for galidesivir in Marburg and Ebola studies
September 17, 2025 - - Australian Biotech -
Australian Dementia Network Registry wants access to 'turning point' therapies
September 17, 2025 - - Latest News